KHN: Seniors Face Crushing Drug Costs as Congress Stalls on Capping Medicare Out-Of-Pockets
Sharon Clark is able to get her life-sustaining cancer drug, Pomalyst — priced at more than $18,000 for a 28-day supply — only because of the generosity of patient assistance foundations.
Clark, 57, a former insurance agent who lives in Bixby, Oklahoma, had to stop working... Read more
KHN – Analysis: As Seniors Get Sicker, They’re More Likely To Drop Medicare Advantage Plans
By Fred Schulte
Kaiser Health News is a national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.
When Sol Shipotow enrolled in a new Medicare Advantage health plan earlier this year, he expected to keep the doctor who treats hi... Read more
